Chemeq claims chicken growth success in antimicrobial tests
20 June, 2002 by Melissa TrudingerAn independent study using a polymeric antimicrobial designed by Perth-based biotech Chemeq has demonstrated increased growth rates in chickens at 10 per cent of the dose originally tested in poultry, according to the company.
Autogen discovers gene link between heart disease and diabetes
20 June, 2002 by Tanya HollisGene-discovery company Autogen (ASX: AGT) has discovered a genetic link between diabetes and heart diseases in humans.
BioProspect insecticide set for global field trials
20 June, 2002 by Tanya HollisA natural Western Australian insecticide is to be tested in field trials across Australia, Asia the United States and Europe under an agreement between BioProspect and Nufarm.
Biota names new CEO
20 June, 2002 by Tanya HollisInfection and inflammation drug developer Biota Holdings has named Peter Molloy as its new chief executive, replacing Dr Hugh Niall who is retiring this year.
Agriculture, environment feature in CRC applications
19 June, 2002 by Iain ScottApplications focusing on agriculture, the environment and medical research feature highly in the latest round of applications for funding under the Cooperative Research Centre (CRC) program.
Cultivating hairy roots for herbal medicine
19 June, 2002 by Melissa TrudingerA new technology for growing plant tissues in fermentation tanks may allow large-scale production of the bioactive components of herbal medicines like Echinacea, ginseng and Gynostemma.
Ozgene in US deal to advance its GE rodent program
19 June, 2002 by Tanya HollisAn Australian company will soon be offering genetically altered rodents modified at the single-cell stage to maximise efficiencies.
Amphibian adhesive may have wound appliations
19 June, 2002 by Melissa TrudingerScientists at the University of Adelaide and CSIRO Molecular Science are investigating a novel 'glue' from frogs, which could have applications as a bioadhesive for surgical wounds.
CSL blood supply contract renewed
19 June, 2002 by Melissa TrudingerThe Federal government has renewed its contract with CSL to supply blood to blood banks and pathology labs for use in diagnostic procedures.
Environmental biotech: Innovative research environment
18 June, 2002 by Melissa TrudingerIn the first two rounds of Biotechnology Innovation Fund (BIF) grants, five companies with a clearly environmental slant obtained funding. In the first round, these included Pestat, which is commercialising immunocontraceptive mechanisms developed by the CRC for biological control of pest animals, and Orica Australia, which is developing enzyme-based methods for pesticide degradation.
Environmental biotech: Bugs and biotechnology
18 June, 2002 by Melissa TrudingerWith alarm bells ringing over genetically modified organisms and their potential effects on the environment, stories about how biotechnology is also being used to improve the environment are harder to find.
Top-seeded research
18 June, 2002 by Pete YoungQueensland research is cutting the time and cost of seed line improvements by using DNA markers to identify high-yielding sunflower seeds.
Cerylid seals US Anadys deal
18 June, 2002 by Tanya HollisPrivate drug discovery and genomics company Cerylid Biosciences has clinched a deal with Anadys Pharmaceuticals in the United States to search for new anti-infective compounds.
Sheep genomics program proposed
18 June, 2002 by Melissa TrudingerIn a new approach to animal science, Meat and Livestock Australia (MLA) is meeting with scientists with a wide range of experience in medical and animal sciences to establish a functional genomics program for the sheep industry.
Panbio celebrates first FDA approval
17 June, 2002 by Melissa TrudingerIn a first for the company, Panbio's diagnostic panel for glandular fever has been approved by the US Food and Drug Administration (FDA).
